C07C 259/20
With at least one nitrogen atom of hydroxamidine groups bound to another
Official title: with at least one nitrogen atom of hydroxamidine groups bound to another nitrogen atom
C07C259/20 (With at least one nitrogen atom of hydroxamidine groups bound to another) appears on 10 US grants and 5 published applications in this corpus.
Search patents in C07C- Granted patents
- 10
- Published applications
- 5
- Assignees
- 6
- Inventors
- 22
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for preparing dihydroxyammonium 5,5′-bistetrazole-1,1′diolate25 Mar 2025US 12,258,322 B2Agency for Defense Development
- Compounds for treating proliferative disorders9 Dec 2014US 8,907,131 B2Synta Pharmaceuticals Corp.
- Compounds for treating proliferative disorders4 Jun 2013US 8,455,686 B2Synta Pharmaceuticals Corp.
- Compounds for treating proliferative disorders10 Jan 2012US 8,093,425 B2Synta Pharmaceuticals Corp.
- Biaryl compounds as serine protease inhibitors30 Aug 2005US 6,936,719 B2BioCryst Pharmaceuticals, Inc.
- Methods for preparing dihydroxyammonium 5,5'-bistetrazole-1,1'diolate26 Dec 2024US 2024/0425466 A1Agency for Defense Development
- Compounds for treating proliferative disorders30 Jan 2014US 2014/0031429 A1Synta Pharmaceuticals Corp.
- Compounds for treating proliferative disorders19 Apr 2012US 2012/0095103 A1Synta Pharmaceuticals Corp.
- Compounds for treating proliferative disorders22 Jan 2009US 2009/0023736 A1Synta Pharmaceuticals Corp.
- Biaryl compounds as serine protease inhibitors19 Aug 2004US 2004/0162281 A1BioCryst Pharmaceuticals, Inc.
Most cited
By later US patents
- Biaryl compounds as serine protease inhibitors57US 6,699,994 B1BioCryst Pharmaceuticals, Inc. · 2004
- Biaryl compounds as serine protease inhibitors21US 6,936,719 B2BioCryst Pharmaceuticals, Inc. · 2005
- O-benzyl oxime ether derivatives and their use as pesticides6US 6,211,240 B1Novartis AG · 2001
- Compounds for treating proliferative disorders5US 8,093,425 B2Synta Pharmaceuticals Corp. · 2012
- Compounds for treating proliferative disorders4US 8,455,686 B2Synta Pharmaceuticals Corp. · 2013